Reference
Digklia A, et al. First communication on the efficacy of combined 177 Lutetium-PSMA with immunotherapy outside prostate cancer. Journal for ImmunoTherapy of Cancer 10: e005383, No. 10, 26 Oct 2022. Available from: URL: http://www.immunotherapyofcancer.org/
Rights and permissions
About this article
Cite this article
Antineoplastics/Lutetium-177-psma-imaging-and-therapy. Reactions Weekly 1942, 49 (2023). https://doi.org/10.1007/s40278-023-32658-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-32658-3